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In vitro and in vivo Expression of Interstitial
Collagenase/MMP-1 by Human Mast Cells
NICK DI GIROLAMO* and DENIS WAKEFIELD
Inflammation Research Unit, School ofPathology, The University ofNew South Wales, Sydney, 2052, Australia
Degradation of the extracellular matrix occurs under physiological and pathological condi-
tions, thought to be principally mediated by a family of neutral proteolytic enzymes termed
the matrix metalloproteinases (MMPs). The present study was initiated to determine whether
mast cells have the ability to produce these proteases in diseased and normal human tissue.
Immunohistochemistry and in situ hybridization was performed to localize interstitial colla-
genase protein and mRNA transcripts in diseased human tissue. The human mast cell line
HMC-1 was cultured under serum free conditions, stimulated with phorbol mystrate acetate
(PMA) and supernatants analyzed by Western blotting and zymography to determine the pro-
file of secreted MMPs. The dog mast cell line BR, known to secrete gelatinolytic enzymes,
was used in parallel studies. Total RNA was extracted and analyzed by RT-PCR for the
expression of tissue inhibitors of MMP (TIMPs). Collagenase-1 protein and mRNA were
expressed by tryptase and chymase positive human mast cells in all tissue analyzed. This pro-
teinase wa also detected in the cytoplasm and conditioned media of HMC-1 cells. PMA
induced gelatinolytic activity in both mast cell lines examined. TIMP-1 immunoreactivity
was detected and TIMP-1, and-2 (but not TIMP-3) mRNA transcripts were amplified from
HMC-1 cells. This is the first demonstration of the expression of collagenase-1 by human
mast cells in both inflamed and normal tissues, and by a human mast cell line. MMPs secreted
by these cells could contribute to the extensive matrix lysis characteristic of diseases such as
rheumatoid arthritis and inflammatory ocular disorders. Alternatively collagenase-1 produc-
tion by mast cells may play a critical role in cell invasion and migration into sites of inflam-
mation.
Keywords: collagenase, gelatinase, mast cells, matrix metalloproteinase, TIMP
INTRODUCTION
Recent studies have focused on the potential impor-
tance of mast cells in a variety of inflammatory disor-
ders affecting the integrity of the connective tissue
matrix such as rheumatoid arthritis (RA) (Godfrey et
al., 1984) and asthma (Galli, 1993). Mast cells have
been shown to play a key role in initiating inflamma-
tory responses, via their release of pro-inflammatory
mediators such as cytokines (Gordon and Galli,
1990), growth factors (Powers et al., 1997), chemok-
ines (Wang et al., 1998; Moller et al., 1993), hista-
mine and proteases (McNeil, 1996). Proteases such as
tryptase and chymase serve as specific markers for
mast cells (Schwartz, 1994). Tryptase has been shown
to degrade fibronectin (Lohi et al., 1992) and chy-
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mase is active against basement membrane proteins
such as collagen type IV and V, laminin and fibronec-
tin (Vartio et al., 1981). Characteristically, mast cells
are localized adjacent to blood vessels and amongst
resident connective tissue and epithelial cells, hence
their ability to promptly influence their microenviron-
ment upon degranulation.
Matrix metalloproteinases (MMPs) are a family of
neutral proteolytic enzymes active against all compo-
nents of the extracellular matrix (ECM) (Stetler-Ste-
venson, 1996). These enzymes are divided into four
subclasses depending on substrate specificity. They
include the collagenases (collagenase-1, -2, -3),
which are capable of cleaving collagens types I, II,
and III at a single locus. The gelatinases, which con-
sist of gelatinase A and gelatinase B, preferentially
degrade denatured collagens (gelatins) and type IV
collagen (the main constituent of basement mem-
branes). The stromelysins, which comprise strome-
lysin-1, -2,-3 and matrilysin, have broad substrate
specificity, and are capable of digesting a number of
ECM proteins such as laminin, fibronectin, vitronec-
tin, and proteoglycans. Finally, the membrane-associ-
ated MMPs (MT-MMPs) can activate other MMPs
and degrade some fibrillar collagens.
Under normal physiological conditions, the process
of connective tissue remodeling by MMPs occurs
under stringent control. Uncontrolled remodeling
generally leads to degradative pathologies, which are
usually attributed to a breakdown in the MMP regula-
tory mechanism. Regulation of MMPs occurs at the
level of gene transcription, proenzyme activation, and
inhibition via the action of specific naturally occur-
ring tissue inhibitors ofMMPs (TIMPs). Most MMPs
are not constitutively expressed, but can be induced
by various stimuli including; phorbol ester, growth
factors, cytokines (Mauviel, 1993; Ries and Petrides,
1995) oncogene products, and cell-to-cell or
cell-to-matrix interactions. The activity of MMPs on
ECM proteins is inhibited by the TIMPs. TIMPs bind
MMPs forming a stable noncovalent and irreversible
1:1 stoichiometric complex. In addition to their roles
as MMP inhibitors, TIMPs display growth factor-like
activity (Stetler-Stevenson et al., 1992) and promote
apoptosis (Guedez et al., 1998).
MMPs are secreted as latent pro-enzymes which
require activation in the extracellular space. In addi-
tion to their activation by organomercurials, plasmin,
trypsin, chymotrypsin, neutrophil elastase, and other
MMPs, it has also been demonstrated that serine pro-
teases (derived from mast cells) are capable of acti-
vating MMPs. The ability of purified skin mast cell
chymase to activate human interstitial pro-colla-
genase has been examined (Saarinen et al., 1994) and
results have demonstrated the cleavage of pro-colla-
genase in a time and dose dependent manner. The
mast cell tryptase-dependent activation of pro-colla-
genase has been shown to be dependent entirely on
the activation of pro-stromelysin (Gruber et al.,
1989). Despite these investigation, the precise mecha-
nism(s) ofMMP activation in vivo remain unclear.
Observations of the association of mast cells with
areas of connective tissue destruction and MMP
expression have previously been reported at sites of
tumor invasion (Dabbous et al., 1986), at regions of
joint destruction in RA (Tetlow and Woolley, 1995;
Gotis-Graham and McNeil, 1997), in areas of matrix
degradation in scleritis (Di Girolamo et al., 1998a; Di
Girolamo et al., 1998b), in atherosclerotic plaques
(Johnson et al., 1998; Kaartinen et al., 1998) and in
the human endometrium throughout the menstrual
cycle (Salamonsen and Woolley, 1996). Although the
role of mast cells have been extensively studied, the
role of mast cell proteinases is not entirely clear. This
study was initiated to explore the capacity of human
mast cells to produce proteinases which specifically
degrade matrix components.
RESULTS
Collagenase-1 Is Expressed By Mast Cells
In Diseased And Normal Human Tissue
Diseased and normal human tissue was serially sec-
tioned and analyzed immunohistochemically to deter-
mine the capacity of mast cells to express
collagenase-1. The results of this study demonstrated
firstly, the abundance of mast cells in diseased tissuePRODUCTION OF COLLAGENASE- BY HUMAN MAST CELLS 133
FIGURE In vivo expression of collagenase-1 by human mast cells. Serial (4tm) sections of diseased human synovial tissue (A-C), ptery-
gium tissue (D-F) and normal human conjunctiva (G-I) were immunohistochemically analyzed for the expression of tryptase (A, D, G), col-
lagenase-1 (B, E, H), chymase (C, F, I). Some sections were incubated with preabsorbed anti-collagenase-1 mAb (inset C), an isotype control
Ab (inset F) or in the absence of a primary Ab (inset I). Immunoreactivity is denoted by the red cytoplasmic staining, with hematoxylin
establishing the background nuclear staining. Arrowheads and arrows identify the same mast cell in two or three contiguous tissue sections
respectively. These results are representative of all tissue examined. Original magnification X500 for sections A-C and X640 for sections D-I
(see Color Plate IX at the back of this issue)
and their typical perivascular localization (Fig A-F).
In contrast, fewer mast were detected in all normal
tissue analyzed (Fig 1 G-I). Mast cells were identified
based on the specificity of two monoclonal antibodies
(mAbs) directed against tryptase and chymase, which
are proteases stored in mast cells granules. Sections of
synovial tissue derived from a patient with RA dem-
onstrated intense immunoreactivity for collagenase-1
in large, round, granular cells (Fig 1B), and in irregu-
lar shaped cells resembling connective tissue fibrob-
lasts and synovial linning macrophage-like cells (data
not shown, and McCachren et al., 1990). Serial tissue
sections revealed the identity of these cells as tryptase
(Fig 1A) and chymase (Fig 1C) positive mast cells.134 NICK DI GIROLAMO and DENIS WAKEFIELD
Corroborating evidence was generated using diseased
ocular tissue (Fig D-F), whereby collagenase-1 pro-
ducing cells (Fig 1E), co-expressed chymase
(Fig 1F). Similarly, tryptase (Fig 1G) and chymase
(Fig lI) positive mast cells in normal ocular tissue
stained positively for collagenase-1 (Fig 1H),
although the immunoreactive staining was much
weaker than that observed in diseased tissue. Identical
staining patterns were observed with all other dis-
eased and normal human tissue examined. Of note
was the diffuse extracellular as well as specific
cell-associated staining observed with the tryptase
Ab. This pattern of staining has previously been
observed in our laboratory (Gotis-Graham and
McNeil, 1997; Gotis-Graham et al., 1998), and is
thought not to be associated with mast cell degranula-
tion. No staining was observed when tissue sections
were incubated with pre-absorpted collagenase-1
mAb (Fig 1C, inset), an isotype control Ab (Fig 1F,
inset), or when the primary Ab was omitted (Fig lI,
inset).
Collagenase-1 mRNA Is Localized To Mast Cells
In Human Tissue
In situ hybridization using a digoxigenin-labeled ribo-
probe on human pterygium (Fig 2A) and other dis-
eased and normal tissue (micrographs not shown)
demonstrated specific cytoplasmic hybridization sig-
nal for collagenase-1 mRNA transcripts in toluidine
blue positive mast cells (Fig 2B). Additional hybridi-
zation signal for this transcript was observed in resi-
dent connective tissue cells (data not shown).
Sections hybridized with the corresponding sense
probe resulted in no signal (Fig 2A, inset). Examina-
tion of all tissues for TIMP-1 mRNA by ISH resulted
in the absence of this transcript from mast cells using
this method (data not shown).
Collagenase-1 Is Produced By Cultured Human
Mast Cells (HMC-I)
Although HMC-1 cells are an immature and a malig-
nant mast cell line, to our knowledge this is the only
human mast cell line available which may best repre-
sent mast cells in vivo. As previously shown (Butter-
field et al., 1988), and as demonstrated in Figure 3,
these cells contain distinct granular immunoreactivity
for tryptase (Fig 3A) but not chymase (A, inset). Like
their in vivo counterparts, HMC-1 expressed cytoplas-
mic collagenase-1 (Fig 3B) and some cells contained
gelatinase B (Fig 3C) and TIMP-1 (Fig 3D) immuno-
reactivity. TIMP-2 and-3 could not be detected by
this method (micrographs not shown).
FIGURE 2 Human mast cells express collagenase-1 mRNA. Sections of pterygium tissue were hybridized with a digoxigenin-labeled colla-
genase-1 antisense (A) or sense (inset A) riboprobe. An adjacent section was stained with toluidine blue (B) to detect all mast cells. Hybrid-
ization signal is denoted by the blue/purple cytoplasmic staining and neutral red distinguishes the cell nuclei. Arrowheads identify the same
mast cell in two sequential tissue sections. Similar results were obtained with all other diseased and normal tissue examined. Original magni-
fication X313 (see Color Plate X at the back of this issue)PRODUCTION OF COLLAGENASE-1 BY HUMAN MAST CELLS 135
FIGURE 3 HMC-1 cells express collagenase-1, gelatinase B, and TIMP-1. HMC-1 cells were cultured, pelleted, fixed, and sectioned for his-
tochemical analysis using an nti-tryptase mAb (A), anti-chymase Ab (inset A), anti-collagenase-1 mAb (B), anti-gelatinase B mAb (C) or
an anti-TIMP-1 mAb (D). When an isotype control Ab was used, no immunoreactivity was observed (inset B). Immunoreactivity is denoted
by the red cytoplasmic staining. Cells were counterstained with hematoxylin. This data is representative of four separate experiments. Origi-
nal magnification X500 (see Color Plate XI at the back of this issue)
Cell-To-Cell Contact Induces Collagenase-I
Production
To determine whether cell-to-cell contact induced col-
lagenase-1 secretion, HMC-1 cells were co-cultured
with human scleral fibroblasts (HSF) (cells that
express little collagenase-1 even when stimulated
with pro-inflammatory cytokines) (Di Girolamo et al.,
1995). In this set of experiments, HSF were allowed
to grow to semiconfluence, after which HMC-1 cells
were added. Conditioned media (CM) derived from
co-culture experiments displayed increased colla-
genase-1 immunoreactivity (Fig 4, lane 3). In con-
trast, CM derived from HSF or HMC-1 alone
demonstrated little or no reactivity for this proteinase
(Fig 4, lanes 2 and 4 respectively).
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FIGURE 4 Induction of collagenase-1 in co-cultures. Human
scleral fibroblasts were cultured to semi-confluence and co-cul-
tured with HMC-1 cells. Supernatants from the scleral fibroblasts
cultured alone (lane 2), HMC-1 cultured alone (lane 4), co-cultures
(lane 3) and CM from PMA stimulated human synovial fibroblasts
(lane 5) were analysed by immunoblot using a collagenase-1 mAb.
This blot is representative of three separate experiments136 NICK DI GIROLAMO and DENIS WAKEFIELD
HMC-1 Cells Secrete Collagenase-1
HMC-1 were cultured under serum-free conditions
over 48 hrs., afterwhich the CM was prepared for
immunoblotting. HMC-1 cells (Fig 5, lane 2) consti-
tutively produced collagenase-1. Increased immuno-
reactivity for this enzyme was observed in the CM of
PMA stimulated mast cells (Fig 5, lane 1). Interest-
ingly, the addition of A23187 (degranulating agent)
resulted in no increase in the intensity of the 54-kDa
immunoreactive band compared to control levels
(Fig 5, lane 3). These results suggest that colla-
genase-1 is not stored in mast cell granules but
secreted upon synthesis. The 54-kDa band detected in
HMC-1 CM co-migrated precisely with the previ-
ously characterized collagenase-1 derived from
human synovial fibroblasts (Fig 5, lane 4). These data
also confirm the specificity of the collagenase-1 mAb
used in Figures 1, 3, and 4.
PMA Induces Gelatinolytic Activity in Mast Cell
Lines
Gelatin-substrate zymography is a powerful tech-
nique, which allows for the detection of gelatinases
from different mammalian species in CM samples.
This arm of the study was initiated to determine the
gelatinolytic profile of HMC-1 cells. No gelatinolytic
bands were found in the supernatants from unstimu-
lated cells (Fig 6, lane 2). However, exposure to PMA
(Fig 6, lane 3) resulted in the induction of a prominent
gelatinolytic band which migrated to 92-kDa,
degraded the gelatin substrate and co-migrated with
gelatinase B produced by the human fibrosarcoma
cell line (HT1080) (Fig 6, lane 6). Gelatinase A was
not detected in HMC-1 supernatants. In parallel, CM
from the dog mast cells (BR), previously shown to
contain gelatinolytic activity (Fang et al., 1996), dis-
played an increased area of clearance in the zymo-
gram (Fig 6, lanes 4 & 5). CM from unstimulated BR
cells contained gelatinase A & B-like bands which
co-migrated with gelatinase A (72-kDa) and gelati-
nase B (92-kDa) produced by HT1080 cells. Cells
treated with PMA secreted higher levels of both pro-
and active gelatinase A and B-like activities, (as
shown by a decrease in MW of approximately
10-kDa) (Fig 6, lane 5). Gels loaded with the identical
samples but incubated in substrate buffer containing
EDTA or 1, 10-phenanthroline (potent inhibitors of
MMPs), resulted in no lytic activity (data not shown),
suggesting that the bands displayed on the zymogram
were derived from MMPs and not from serine protei-
nases. In addition, their migratory pattern and their
potent activity against gelatin were other criteria used
to identify and classify these enzymes as MMPs.
TIMP-1 And-2 But Not TIMP-3 mRNAs Are
Expressed By HMC-1
Although no immunoreactivity for the TIMPs was
observed in mast cells in any human tissue examined,
some immunoreactivity for TIMP-1 was observed in
HMC-1 cells (Fig 3D). The sensitive technique of
RT-PCR was employed to determine the expression of
TIMPs in HMC-1. Of the three TIMPs analyzed,
HMC-1 cells expressed TIMP-1 and-2 mRNAs
(Fig 7A & B respectively). Interestingly, these two
transcripts were differentially regulated, as TIMP-1
mRNA was apparently down-regulated by. PMA
(Fig 7A, lane 2), whereas TIMP-2 was induced by
PMA (Fig 7B, lane 2). TIMP-3 mRNA was not
detected by HMC-1 cells (Fig 7C), but was in human
scleral fibroblasts (HSF) (Fig 7C, lane 3). Amplifica-
tion of GAPDH mRNA (Fig 7D) was identical
between control and PMA stimulated HMC-1 cells,
providing an appropriate control.
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FIGURE 5 HMC-1 cells secrete collagenase-1. CM from PMA
stimulated (lane 1), control (lane 2), and A23187 exposed (lane 3)
HMC-1 cells and supernatants from PMA treated human synovial
fibroblasts (lane 4) were analysed by Western immunoblotting
using a collagenase-1 mAb. A single immunoreactive band migrat-
ing to approximately 54-kDa was observed. This blot is representa-
tive of three individual experimentsPRODUCTION OF COLLAGENASE-1 BY HUMAN MAST CELLS 137
DISCUSSION
Mast cells have been shown to participate in a range
of inflammatory and immunological events such as
acute immediate hypersensitivity reactions, host
defence against parasites, angiogenesis, wound repair
and fibrosis, and connective tissue turnover (McNeil
1996). Such processes are partially mediated by the
large range of bioactive molecules released by these
cells upon activation and degranulation. Along with
the growing list of cytokines, chemokines (Tedla et
al., 1998; Wang et al., 1998; Moller et al., 1993) and
an arsenal of serine proteases stored by mast cells, the
current study has identified a class of enzymes active
against specific matrix components. Evidence of
MMP production by human mast cells was confirmed
in both diseased and normal tissue and in a human
mast cell line. To our knowledge this is the first dem-
onstration of the production ofMMPs by human mast
cells in vivo.
The localization of interstitial collagenase to mast
cells has particular significance, as this enzyme spe-
cifically denatures interstitial collagen type-I, II, and
III, matrix proteins frequently encountered by mast
cells as they migrate ttirough the connective tissue.
Recently, it has been shown that other granulocytes
such as eosinophils use MMPs to migrate through
basement membranes (Okada et al., 1997) and gelati-
nase B has been shown to play a role in neutrophil
migration (Declaux et al., 1996). Alternatively, the
production ofMMPs by mast cells could contribute to
the extensive tissue degradation in diseases such as
RA (Tetlow and Woolley, 1995; Gotis-Graham and
McNeil, 1997), cancer (Dabbous et al., 1986), asthma
(Galli, 1993), inflammatory ocular diseases (Di Giro-
lamo et al., 1998a; Di Girolamo et al., 1998b), and in
the normal remodelling which occurs in the human
endometrium (Salamonsen and Woolley, .1996). It is
interesting to note that these previous studies failed to
identify MMPs in human mast cells. This discrepancy
could have been due to the source of primary Ab, as
the tissue fixative was generally similar to that used in
present study. The specificity of the collagenase-1
mAb used in the current study was verified by anti-
body/antigen preabsorption (Fig 1C, inset), and West-
ern blotting (Figs 4 & 5), where a single
immunoreactive species which migrated to approxi-
mately 54-kDa was observed. Corroborating evidence
has recently been presented by several investigators
who have localized stromelysin-1 (MMP-3) to murine
mast cells (Brownell et al., 1995) and gelatinase B to
dog mast cells (Fang et al., 1996). There is however
one study which disputes the results of the present
study, and suggests that interstitial collagenase actu-
ally binds mast cell granules (Krejci et al., 1992). The
authors of that particular study added exogenous pro-
or active collagenase-1 to frozen or paraffin-embed-
ded sections of normal, malignant and other patholog-
ical human tissue and found that collagenase-1 bound
(via heparin) exclusively to mast cells and mast cell
granules upon degranulation, as opposed to mast cells
themselves producing this enzyme. With respect to
the present study, it is unlikely that mast cells have
bound collagenase-1 from the microenvironment, as
firstly the immunohistochemical data demonstrated
that the immunoreactive staining was cytoplasmic
and not membrane associated (Fig 1B, E, H). In addi-
tion, there was no evidence of degranulation in the tis-
sue sections analyzed. Secondly, mast cells expressed
collagenase-1 mRNA transcripts (Fig 2A), and
thirdly, HMC-1 cells secreted detectable levels of col-
lagenase- 1.
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FIGURE 6 HMC-1 cells secrete gelatinase B. HMC-1 cells (lanes 2
& 3), canine BR mast cells (lanes 4 & 5) and HT1080 (lane 6) were
cultured in serum-free media under control conditions (lanes 2, 4,
6) or stimulated with PMA (lanes 3 & 5) and the CM analyzed by
gelatin zymography. A low MW standard was run in parallel (lane
1). This data is representative of four experiments138 NICK DI GIROLAMO and DENIS WAKEFIELD
TABLE Primer pairs used for PCR analysis
(a) TIMP- F
R
(b) TIMP-2zx F
R
(c) TIMP-3
+/- F
R
(d) GAPDH* F
R
51-TGC ACC TGT GTC CCA CCC CAC CCA CAG ACG-31
51-GGC TAT CTG GGA CCG CAG GGA CTG CCA GGT-31
51-GCA GAT GTA GTG ATC AGG GC-3
5-TAT GGG TCC TCG ATG ACG AG-31
51-CCA TCA AGC AGA TGA AGA TGT ACC-31
51-GGT AGT AGC AGG ACT TGA TCT TGC-31
5-TGA TGA CAT CAA GAA GGT GGT GAA G-3
5-TCC TTG GAG GCC ATG TGG GCC AT-31
Abbreviations: GAPDH; Glyceraldehyde 3 phosphate dehydrogenase, F; Forward primer, R; Reverse primer. Previous studies (+ Di
Girolamo et al., 1998b; A Stetler- Stevenson et al., 1990; _k Kenney et al., 1998; *Schimonovitz et al., 1994) have successfully used these
primer sets to amplify the respective gene targets.
The function of mast cell serine proteases chymase
and tryptase are yet to be fully elucidated, although
they have been shown to have differing substrate spe-
cificity. Saarinen et al (1994) have recently demon-
strated the specific cleavage of procollagenase-1 by
human mast cells chymase, and similar data was pre-
sented by Suzuki et al (1995) who showed that rat
mast cell proteinase II (an enzyme equivalent to
human chymase) activated procollagenase-1. The
Western blotting data presented in the current study
showed that the collagenase-1 secreted by HMC-1
cells was present in tile latent or zymogen form. This
is not surprising since HMC-1 cells do not express
chymase. It is however tempting to speculate that the
collagenase-1 secreted by human chymase positive
mast cells in vivo, may be promptly activated upon
degranulation. This was recently demonstrated by
Fang et al (1996) who showed that not only were dog
mast cells capable of producing gelatinase B, but this
enzyme could be activated by chymase derived from
the same cells after degranulation. Similarly, we have
previously demonstrated that HMC-1 cells are capa-
ble of producing stromelysin-1, and that supernatants
derived from these cells contained active enzyme (Di
Girolamo et al., 1998a). It was speculated that mast
cell derived products (possibly tryptase) were contrib-
uting to this activation.
Whereas previous reports have indicated that mast
cell derived serine proteases are capable of activating
MMPs produced by other cells, the data presented in
the current study suggest that human mast cells are
capable of producing both families of enzymes.
Therefore, it is tempting to speculate that the serine
proteases released by mast cells upon degranulation
may function to activate collagenase-1 produced by
the same cell. The nett effect may be localized tissue
damage in diseased states. Alternatively, under nor-
mal physiological conditions, MMPs may be required
for the passive migration of mast cells through con-
nective tissues. Data supporting this hypothesis was
demonstrated in Figure 1H, where it was apparent
that the staining intensity for collagenase-1 in mast
cells was diminished in normal compared to diseased
human tissue. Similarly, collagenase-1 production
was shown to be induced in HMC-1 cells. Future
studies will be aimed at determining the relative con-
tribution of MMPs by mast cells versus other inflam-
matory and resident connective tissue cells. In
summary, our results imply that mast cells play a crit-
ical role in tissue destruction and matrix turnover in
both pathological and physiological conditions.
MATERIALS AND METHODS
Diseased And Normal Human Tissue
Synovial tissue specimens from patients with rheuma-
toid arthritis (n=6), human pterygium specimens
(n=6), inflamed tonsilar tissue (n=4), normal syn-
ovium (n=3), normal conjunctiva (n=8), and normal
small bowel (n=3) were obtained from archival orPRODUCTION OF COLLAGENASE-1 BY HUMAN MAST CELLS 139
FIGURE 7 RT-PCR analysis for TIMP mRNA expression in
HMC-1 cells. Total RNA was extracted from HMC-1 cells (lane
& 2) and from HSF (lane 3) under control conditions (lanes & 3)
or after exposure to PMA (lane 2). In the presence of reverse tran-
scriptase and gene specific primers for TIMP-1 (A), TIMP-2 (B),
TIMP-3 (C) and GAPDH (D), products of predicted size were
formed. When no TIMP-1 primers were included (E lane 1), no
reverse transcriptase was used (E lane 2) and no template was
added (E lane 3), no PCR product formed. Product size was esti-
mated with a 100bp ladder (Gibco BRL). These results were
obtained in two other experiments
postmortem material held in the Department of Ana-
tomical Pathology, The Prince of Wales Hospital, and
the Department of Eye Pathology, Sydney Eye Hospi-
tal, Sydney, Australia.
Preparation OfRNA Probes And In Situ
Hybridization
Plasmid cDNAs for human interstitial collagenase-1
and TIMP-1 were manipulated to generate digoxi-
genin-labeled sense and antisense collagenase-1
(530bp) and TIMP-1 (551bp) riboprobes as previ-
ously described (Di Girolamo et al., 1995; Di Giro-
lamo et al., 1997; Di Girolamo et al., 1998b).
Non-isotopic in situ hybridization (ISH) was per-
formed as previously described using these probes on
4m sequential tissue sections (Di Girolamo et al.,
1995; Di Girolamo et al., 1997; Di Girolamo et al.,
1998b).
lmmunohistochemical Analysis
Diseased and control tissue was cut (2-4tm),
mounted, dried, and processed for immunohistochem-
istry (IHC). Sections were de-paraffinized, quenched
for endogenous peroxidase as previously described
(Di Girolamo et al., 1998b), and incubated with a 1:5
dilution of pre-immune goat serum for 30 min. Mouse
primary mAbs for human tryptase, isotype control
IgG (Dako, Carpinteria, CA), a biotinylated human
chymase (Chemicon, Temecula, CA), human colla-
genase-1, gelatinase B, and TIMP-1 (ICN Biochemi-
cals, Sydney, Australia) were incubated with tissue
sections for 30 min., after which a 1:200 dilution of a
biotinylated secondary goat anti-mouse Ab was
applied for 30 min. Sections were extensively washed
in TBS and a 1:100 dilution of HRP-conjugated
streptavidin (Dako Corp, Carpinteria, CA) was added
for 60 min., followed by the addition of
3-amino-9-ethylcarbazole (AEC; Sigma, Sydney,
Australia). Sections were counterstained with hema-
toxylin, viewed under light microscope and photo-
graphed.140 NICK DI GIROLAMO and DENIS WAKEFIELD
Metachromatic Staining
Tissue sections were prepared as per IHC, except that
after dewaxing each section was treated with 0.5N
HC1 for 10 min. then stained for 90 min. with a solu-
tion consisting of 1% toluidine blue (BDH Chemicals,
Sydney, Australia) in 0.5N HC1. Sections were not
counter-stained but washed in water and briefly
de-hydrated through increasing grades of alcohol.
This staining procedure was used as an alternative
method for detecting mast cells in human tissue.
Cell Culture
The human mast cell line HMC-1 was a generous gift
from Dr J.H. Butterfield (Mayo Clinic, Rochester,
MN, USA) and the canine mast cell line BR was a
kind gift from Dr K.C. Fang (CVRI, UCSF, CA,
USA). These cells were cultured in 75cm2 tissue
flasks (Nunc, Roskilde, Denmark) in RPMI (Trace
Biosciences, Sydney, Australia) supplemented with
10% FBS (Trace Biosciences) and 100 Units/mL pen-
icillin and 100 gg/mL streptomycin (Trace Bio-
sciences). All cell culture media and solutions were
filtered to minimize endotoxin as previously
described (Di Girolamo et al., 1997; Di Girolamo et
al., 1998b). Cells were extensively washed in PBS,
counted and seeded at 2.5 106cells/mL in 75cm2
flasks in serum-free media (SFM; 0.2% BSA/EMEM)
with or without 10 ng/mL PMA (Sigma, Sydney,
Australia) or treated with A23187 (Sigma). For
co-culture experiments, human scleral fibroblasts
(HSF) were grown to semi-confluence (each flask
containing approximately 2 106 cells), extensively
washed with PBS and 2 106 HMC-1 cells added.
For some experiments, CM and RNA was harvested
after 48 hrs. and stored in aliquots at-70C until used
in further analyses. Other cells used in the present
study included: human synovial fibroblasts from a
patient with RA and the human fibrosarcoma cell line
HT1080 (American Tissue Culture Collection, Rock-
ville, MD), cells known to secrete several species of
MMPs and TIMPs.
Extraction OfRNA And RT-PCR Analysis
Total RNA was extracted as previously described (Di
Girolamo et al., 1997; Di Girolamo et al., 1998b).
Reverse transcription was performed according to the
manufacturer’s instructions, using the "Preamplifica-
tion System for First Strand cDNA Synthesis Kit"
(Gibco BRL, Gaithersburg, MD). Aliquots (lgL) of
cDNA were amplified by PCR using 100nM each of
the forward and reverse gene specific primer (GSP)
(see Table I), using similar conditions to those previ-
ously described (Di Girolamo et al., 1998b).
Semi-quantitative PCR was established by terminat-
ing reactions at regular intervals of 10, 15, 20, 25, 30,
and 35 cycles for each primer pair to ensure that the
products formed were within the linear portion of the
amplification curve. PCR conditions of temperature,
cycle number and length, and restriction enzyme
digestions were performed precisely as described pre-
viously (Di Girolamo et al., 1998b). Products were
visualized on 1.2% agarose gels stained with ethidium
bromide.
SDS-PAGE Gelatin-Substrate Zymography
Gelatin-substrate zymography was performed as pre-
viously described (Di Girolamo et al., 1997; Di Giro-
lamo et al., 1998b). Some gels were incubated with 1,
10-phenanthroline (lmmol/L) or EDTA (10mmol/L)
(Sigma), both potentMMP inhibitors.
Western Blot Analysis
Western blotting was performed as previously
described (Di Girolamo et al., 1997; Di Girolamo et
al., 1998a; Di Girolamo et al., 1998b) using a mouse
anti-human collagenase-1 mAb (ICN Biochemicals,
Sydney, Australia). Membranes were placed in a
chemiluminescent reagent for non-radioactive detec-
tion of proteins (Dupont, Sydney, Australia) to
amplify the immunoreactive signal, then exposed to
X-ray film.PRODUCTION OF COLLAGENASE-1 BY HUMAN MAST CELLS 141
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